Screening for systemic manifestations of vascular malformations in patients with hereditary haemorrhagic telangiectasia (Osler disease);Exploración multiorgánica de los pacientes con telangiectasia hemorrágica hereditaria (enfermedad de Osler)

Acta Otorrinolaringologica Espanola

Volumn 59, Issue 9, 2008, Pages 463-468

  Pohl, Ana Cerra ^a   Werner, Jochen Alfred ^a   Folz, Benedikt Josef ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Karl Hansen Klinik   (Germany)

Author keywords

Hereditary haemorrhagic telangiectasia; Osler disease; Systemic manifestations

Indexed keywords

CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; EPISTAXIS; RENDU OSLER WEBER DISEASE; REVIEW; SCREENING; SKIN MANIFESTATION; SYMPTOM; TELANGIECTASIA;

EID: 56049097639     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(08)75119-7     Document Type: Review

References (46)

1. Maher CO, Piepgras DG, Brown RD, Friedman JA, Pollock BE. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke. 2001;32:877-82.
2. Folz BJ, Cerra Wollstein A, Alfke H, Dünne AA, Lippert BM, Görg K, et al. The value of screening for arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Oto-Rhino-Laryngology. 2004;261:509-16.
3. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet, 2000;91:66-7.
4. Pasche B, Cerra Wollstein A, Zoll B, Folz B. Rendu-Osler-Weber-Syndrom. Dtsch Arztbl. 2003;100:A490-3.
5. Azuma J. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest. 2000;47:81-90.
6. Jacobson BS. Hereditary hemorrhagic telangiectasia. Amodel for blood vessel growth and enlargement. Am J Pathol. 2000;156:737-42.
7. Bergler W, Götte K. Hereditary hemorrhagic telangiectasia: a challenge for the clinician. Eur Arch Otorhinolaryngol. 1999;256:10-5.
8. Lund V, Howard DJ. Atreatment algorithm for the management of epistaxis in hereditary hemorrhagic teleangiectasia. Am J Rhinol. 1999;13:319-22.
9. Werner JA, Geisthoff UW, Lippert BM, Rudert H. Behandlung der rezidivierenden Epistaxis beim Morbus Rendu-Osler-Weber. HNO. 1997;9:673-81.
10. Werner JA, Lippert BM, Geisthoff UW, Rudert H. Nd:YAG-Lasertherapie der rezidivierenden Epistaxis bei hereditärer hämorhagischer Telangiektasie. Laryngo Rhino Otol. 1997;76:495-501.
11. Werner JA. Behandlungskonzept der rezidivierenden Epistaxis bei Patienten mit hereditärer hämorrhagischer Telangiektasia. HNO. 1999;47:525-7.
12. Young A. Closure of the nostrils in atrophic rhinitis. J Laryngol Otol. 1967;81:515-24.
13. Saunders WH. Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforation. Trans Am Acad Ophthalmol Otolaryngol. 1960;64:500-6.
14. Fischer M, Dietrich U, Labisch C, Zanella FE, Jahnke K. Kritische Beurteilung der Gefäßembolisation bei Morbus Rendu-Osler. Laryngorhinootologie. 1997;76:490-4.
15. Guttmacher AE, Marchuck DA, White RI Jr. Hereditary haemorrhagic telangiectasia. N Engl J Med. 1995;333:918-24.
16. Iqbal M, Rossoff LJ, Steinberg HN, Marzouk KA. Pulmonary arteriovenous malformations: a clinical review. Postgrad Med J. 2000;76:390-4.
17. Kjeldsen AD, Oxhoj H, Andersen PE, Elle B, Jacobsen JP, Vase P. Pulmonary arteriovenous malformations, screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest. 1999;116:432-9.
18. Faughnan ME, Hyland RH, Nanthakumar K, Redelmeier DA. Screening in hereditary hemorrhagic telangiectasia patients. Chest. 2000;118:566-7.
19. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol. 1996;7:787-804.
20. McClausland AM, Hyman C, Winsor T, Trotter AD. Venous distensibility during pregnancy. Am J Obstet Gynecol. 1961;81:472-9.
21. Willemse RB, Mager J, Westermann CJJ, Overtoom TTC, Maser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangectasia. J Neurosurg. 2000;92:779-84.
22. Roman G, Fischer M, Perl DP, Poser CM. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of two cases and review of the literature. Ann Neurol. 1978;4:130-44.
23. Matsubara S, Manzia J, Brugge K, Willinsky RA, Montanera W, Faughnan ME. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiology. 2000;21;1016-20.
24. Djindjian R, Hurth M, Rey A, Houdart R. Angiomes mèdulaires dans la maladie Rendu-Osler. J Neuroradiol. 1974;1:289-350.
25. Morgan T, Mc Donald J, Anderson C, Ismail M, Miller F, Mao R, et al. Intracranial hemorhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Pediatrics. 2002;109:e12.
26. Plauchu H, De Chadarevian P, Bideau A, Robert M. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291-7.
27. Kirchner J, Zipf A, Dietrich CF, Hohmann A, Heyd R, Berkefeld J. Universeller Organbefall bei Morbus Rendu-Osler-Weber: interdisziplinäre Diagnostik und interventionelle Therapie. Z Gastroenterol. 1996;34:747-52.
28. Caselitz M, Chavan A, Manns MP, Wagner S. Die Hereditäre Hämorrhagische Telangiektasie (Morbus Osler-Rendu-Weber) und ihre Manifestation an der Leber. Z Gastroenterol. 2001;39:533-42.
29. Whiting JH, Korzenic JR, Miller FJ, Pollack JS, White RI. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangectasia. J Vasc Interv Radiol. 2000;11:855-8.
30. Chavan A, Galanski M, Wagner S, Caselitz M, Schlitt HJ, Gratz KF, et al. Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations - Experience in five patients. Radiology. 1998;209:735-9.
31. Pfitzmann R, Heise M, Langrehr JM, Steinmüller T, Podrabsky P, Ewert R, et al. Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. Transplantation. 2001;72:237-41.
32. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology. 1986;91:1079-83.
33. Kjeldsen AD, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol. 2000;95:415-8.
34. Iddan G, Meron G, Glukovski A, Swain P. Wireless capsule endoscopy. Nature. 2000;405:417.
35. Chong AKH, Taylor ACF, Miller AM, Desmond PV. initial experience with capsule endoscopy at a major referral hospital. MJA. 2003;178:537-40.
36. Weaver GA, Wilk HE, Olson JE. Successful endoscopic electrocoagulation of gastric lesions of hereditary hemorrhagic telangiectasia responsible for repeated hemorrhage. Gastrointest Endosc. 1981;27:181-4.
37. Van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet. 1990;335:953-5.
38. Naveau S, Aubert A, Poynard J, Chaput JC. Longterm results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci. 1990;34:821-5.
39. Sargeant IR, Loizou LA, Rampton D, et al. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993;34:470-5.
40. Quitt M, Froom A, Veisler A, Falber V, Sova J, Aghai E. The effect of desmopressin on massive gastrointestinal bleeding in hereditary hemorrhagic telangiectasia unresponsive to treatment with cryoprecipitate. Arch Intern Med. 1990;150:1744-8.
41. De Cenzo JM, Morrisseau PM, Marrocco G. Osler-Weber-Rendu syndrome. Urologist's view. Urology. 1975;5:549-52.
42. Ziani M, Valignat C, Lopez JG, Ruffion A, Plauchu H, Perrin P. Renal arteriovenous malformation requiring surgery in Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia). J Urol. 2000;164:1292-3.
43. Díaz Gallo, Mauri JM, Gil-Vernet Sedo A, Franco E, Alsina J. Hematuria macroscópica recurrente como primera manifestación de la enfermedad de Rendu-Osler. An Med Interna. 1990;7:599-600.
44. Cooke DA. Renal arteriovenous malformations demonstrated angiographically in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). J R Soc Med. 1986;79:744-6.
45. Vase I, Vase P. Ocular lesions in hereditary haemorrhagic telangiectasia. Acta Ophthalmol. 1979;57:1084-90.
46. Brant AM, Schachat AP, White RI. Ocular manifestations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber Disease). Am J Ophtal. 1989;107:642-6.